Skip to main content

Advertisement

Table 7 Summary of subjects with any AE by preferred term (safety set)

From: Efficacy of N,N‘bis-(2-mercaptoethyl) isophthalamide on mercury intoxication: a randomized controlled trial

  Number (%) of subjects
Preferred term NBMI 100 mg (n = 13) NBMI 300 mg (n = 11) Placebo (n = 12) Total (n = 36)
Number of subjects with any AE* 6 (46.2%) 5 (45.5%) 8 (66.7%) 19 (52.8%)
Headache 5 (38.5%) 3 (27.3%) 4 (33.3%) 12 (33.3%)
Abdominal pain upper 1 (7.7%) 1 (9.1%) 2 (16.7%) 4 (11.1%)
Abdominal pain   1 (9.1%) 2 (16.7%) 3 (8.3%)
Diarrhoea 1 (7.7%)   1 (8.3%) 2 (5.6%)
Somnolence 1 (7.7%)   1 (8.3%) 2 (5.6%)
Animal bite   1 (9.1%)   1 (2.8%)
Arthralgia    1 (8.3%) 1 (2.8%)
Back pain    1 (8.3%) 1 (2.8%)
Ear pain 1 (7.7%)    1 (2.8%)
Gastroenteritis 1 (7.7%)    1 (2.8%)
Ingrowing nail 1 (7.7%)    1 (2.8%)
Insomnia    1 (8.3%) 1 (2.8%)
Lip dry    1 (8.3%) 1 (2.8%)
Oropharyngeal pain    1 (8.3%) 1 (2.8%)
Vertigo    1 (8.3%) 1 (2.8%)